Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Cryoport Inc is an integrated freight & logistics business based in the US. Cryoport shares (CYRX) are listed on the NASDAQ and all prices are listed in US Dollars. Cryoport employs 750 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $44.40 |
|---|---|
| 52-week range | $38.72 - $86.30 |
| 50-day moving average | $60.36 |
| 200-day moving average | $61.60 |
| Wall St. target price | $92.56 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.72 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $44.4 from 2022-01-24
| 1 week (2022-01-18) | 1.86% |
|---|---|
| 1 month (2021-12-23) | -25.38% |
| 3 months (2021-10-25) | -43.54% |
| 6 months (2021-07-23) | -25.63% |
| 1 year (2021-01-25) | -38.59% |
|---|---|
| 2 years (2020-01-24) | 128.51% |
| 3 years (2019-01-25) | 358.68% |
| 5 years (2017-01-25) | 1,296.23% |
Valuing Cryoport stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cryoport's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cryoport's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10.1 million.
The EBITDA is a measure of a Cryoport's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $214.5 million |
|---|---|
| Gross profit TTM | $36.3 million |
| Return on assets TTM | -1.41% |
| Return on equity TTM | -7.03% |
| Profit margin | -12.57% |
| Book value | $13.83 |
| Market capitalisation | $2.1 billion |
TTM: trailing 12 months
We're not expecting Cryoport to pay a dividend over the next 12 months.
Cryoport's shares were split on a 1:12 basis on 18 May 2015. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cryoport shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Cryoport shares which in turn could have impacted Cryoport's share price.
Over the last 12 months, Cryoport's shares have ranged in value from as little as $38.72 up to $86.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cryoport's is 0.8733. This would suggest that Cryoport's shares are less volatile than average (for this exchange).
Cryoport, Inc. , a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle; and Cryoport Express Advanced Therapy Shippers that provides verification processes to biopharma companies. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. It has a strategic business alliance with Mitsubishi Logistics Corporation to create an integrated medicine supply chain partnership in Japan.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.